RNS Number : 3900D
Tristel PLC
27 October 2020
Tristel plc
("Tristel" or the "Company")
Issue of Equity
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, following the exercise of options by certain employees, it has issued and allotted 9,500 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on or around the 30 October 2020.
The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 46,485,508 Ordinary Shares. Accordingly, the figure of 46,485,508 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Tristel plc
|
Tel: 01638 721 500
|
|
Paul Swinney, Chief Executive Officer
|
|
|
Liz Dixon, Finance Director
|
|
|
|
|
|
Walbrook PR Ltd
|
Tel: 020 7933 8780 or tristel@walbrookpr.com
|
|
Paul McManus
|
Mob: 07980 541 893
|
|
Lianne Cawthorne
|
Mob: 07854 391 303
|
|
|
|
|
finnCap
|
Tel: 020 7220 0500
|
|
Geoff Nash / Giles Rolls, Corporate Finance
|
|
|
Alice Lane, ECM
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
IOEBLBDGRSDDGGR
|
